Cargando…

The role of antimalarials in lupus nephritis: a review

Detalles Bibliográficos
Autores principales:	Lee, Senq-J, Silverman, Earl D, Bargman, Joanne M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403032/ http://dx.doi.org/10.1186/1546-0096-10-S1-A29

Ejemplares similares

Pediatric lupus nephritis: impact of ethnicity on histological subtype and initial presentation
por: Jurencak, R, et al.
Publicado: (2008)

MicroRNA's role as biomarkers of lupus nephritis in children
por: Abulaban, Khalid, et al.
Publicado: (2014)

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008)

Developing consensus treatment plans for proliferative lupus nephritis in childhood-onset systemic lupus erythematous
por: Mina, Rina, et al.
Publicado: (2012)

The effect of juvenile systemic lupus erythematosus serum activated macrophages on a lupus nephritis model
por: Vernon, April S, et al.
Publicado: (2014)

Quality of life in adolescents with recently diagnosed childhood-onset systemic lupus erythematosus
por: Tuck, Sarah, et al.
Publicado: (2012)

Urinary VCAM-1 as a biomarker of lupus nephritis disease activity
por: Smith, Eve, et al.
Publicado: (2014)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

PReS-FINAL-2354: Laboratory investigation of the role of toll-like receptros on kidney cells in pathogenesis of lupus nephritis
por: Sen, E, et al.
Publicado: (2013)

PReS-FINAL-2279: Lupus nephritis in a Colombian cohort of pediatric patients
por: Diaz Maldonado, AS, et al.
Publicado: (2013)

PReS-FINAL-2310: Successful rituximab treatment in a 14 year-old boy with lupus nephritis
por: Torrente-Segarra, V, et al.
Publicado: (2013)

The 1000 Canadian faces of systemic lupus erythematosus: effect of ethnicity on baseline pediatric data
por: Levy, Deborah M, et al.
Publicado: (2012)

PReS-FINAL-2299: Novel biomarkers for the assessment of pediatric systemic lupus erythematosus nephritis (preliminary report)
por: Koutsonikoli, A, et al.
Publicado: (2013)

Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
por: Trachana, M, et al.
Publicado: (2011)

Antimalarial drugs: unexpected evolutionary consequences
por: Schneider, Petra, et al.
Publicado: (2010)

Discovering antimalarials with a differential mode of action
por: Sanz, Laura, et al.
Publicado: (2014)

Effective use of rituximab in combination with low dose cyclophosphamide in childhood onset systemic lupus erythematosus (SLE) with relapsing class IV nephritis
por: Miettunen, PM, et al.
Publicado: (2008)

A framework for assessing the risk of resistance for antimalarials in development
por: Ding, Xavier C, et al.
Publicado: (2012)

Antimalarial treatment by health care providers in Port Harcourt, Nigeria
por: Ebong, Omotavo O, et al.
Publicado: (2012)

Identification of predictors of bone mineral density trajectories in pediatric Systemic Lupus Erythematosus patients
por: Lim, SHL, et al.
Publicado: (2011)

Aspidosperma species (Apocynaceae) as sources of antimalarials: from the in vitro antiplasmodial activity of extracts to pre-clinical toxicological studies for the development of efficient and safe antimalarial phytomedicines
por: Braga de Oliveira, Alaide, et al.
Publicado: (2014)

The Role of Cytokine in the Lupus Nephritis
por: Iwata, Yasunori, et al.
Publicado: (2011)

The Role of Autophagy in Lupus Nephritis
por: Wang, Linlin, et al.
Publicado: (2015)

A systematic review of published antimalarial clinical trials: parasite clearance of artemisinin-containing regimens in the treatment of uncomplicated malaria
por: Das, Debashish, et al.
Publicado: (2012)

Mechanistic insights into non-immunosuppressive immunophilin ligands as potential antimalarial therapeutics
por: Yoon, Ho Sup, et al.
Publicado: (2010)

Collaborative approaches for Target ID in neglected diseases: identifying new antimalarial targets
por: Lafuente, Maria Jose, et al.
Publicado: (2014)

P18 Steroid-induced malignant hypertension causing cytopenia in a case of lupus nephritis
por: Laila, Deena, et al.
Publicado: (2021)

The role of aldosterone blockade in murine lupus nephritis
por: Monrad, Seetha U, et al.
Publicado: (2008)

In-vitro studies on the sensitivity pattern of Plasmodium falciparum to antimalarial drugs and local herbal extracts
por: Olasehinde, Grace, et al.
Publicado: (2012)

Prevalence and demographics of systemic lupus erythematosus and lupus nephritis among US children with Medicaid coverage, 2002-2004
por: Hiraki, Linda T, et al.
Publicado: (2012)

Differences in the pharmacokinetics of currently approved antimalarial drugs in uncomplicated malaria patients compared to healthy subjects
por: Jain, Jay Prakash, et al.
Publicado: (2012)

A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the antimalarial agents KAE609 and piperaquine (PPQ)
por: Stein, Daniel S, et al.
Publicado: (2014)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

The role of cardiac magnetic resonance imaging in the assessment of systemic lupus erythematosis (SLE)
por: Norman, Wendy, et al.
Publicado: (2009)

Large differences in variability for genes associated with antimalarial drug resistance between samples from Tanzania and Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2014)

OA19 A case of severe refractory lupus enteritis and nephritis that remitted with Obinutuzumab
por: Chakravorty, Mithun, et al.
Publicado: (2022)

Neuropsychiatric lupus in children
por: Costa Reis, P, et al.
Publicado: (2011)

Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence “transmission blocking” assay
por: Lelièvre, Joël, et al.
Publicado: (2012)

Antimalarial market composition and performance in Nigeria and the Democratic Republic of Congo: results from 2013 ACTwatch outlet surveys
por: Littrell, Megan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vug35i5n3gkmu59ert4g63catp